T. Rowe Price Investment Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$420M Buy
+869,556
New +$231M 0.28% 91
2026
Q1
Sell
-44
Closed -$8K 949
2025
Q4
$8K Sell
44
-5
-10% -$836 ﹤0.01% 740
2025
Q3
$10K Buy
+49
New +$8.06K ﹤0.01% 717
2024
Q2
Sell
-330,648
Closed -$24.5M 660
2024
Q1
$24.5M Buy
+330,648
New +$24.5M 0.02% 486

Other funds holding ALAB

T. Rowe Price Investment Management's ALAB Position: Q2 2026 in Review

T. Rowe Price Investment Management opened a new position in Astera Labs (ALAB) in Q2 2026: 869,556 shares worth $420M. The stake represents 0.28% of the portfolio and ranks #91 among its holdings. This is a return to the name: T. Rowe Price Investment Management previously reported a position in ALAB as recently as Q4 2025.

T. Rowe Price Investment Management first reported a position in ALAB in Q1 2024 and has held it in 4 quarters since. 982 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • T. Rowe Price Investment Management held 869,556 shares of Astera Labs worth $420M as of Q2 2026.
  • Astera Labs was a new T. Rowe Price Investment Management position in Q2 2026.
  • Astera Labs made up 0.28% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #91 holding.
  • T. Rowe Price Investment Management first reported a position in Astera Labs in Q1 2024 and has held it in 4 quarters since.
  • 982 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.